586 related articles for article (PubMed ID: 26187810)
1. Three-dimensional versus four-dimensional dose calculation for volumetric modulated arc therapy of hypofractionated treatments.
Ehrbar S; Lang S; Stieb S; Riesterer O; Stark LS; Guckenberger M; Klöck S
Z Med Phys; 2016 Mar; 26(1):45-53. PubMed ID: 26187810
[TBL] [Abstract][Full Text] [Related]
2. Simulation of dosimetry impact of 4DCT uncertainty in 4D dose calculation for lung SBRT.
Liu G; Hu F; Ding X; Li X; Shao Q; Wang Y; Yang J; Quan H
Radiat Oncol; 2019 Jan; 14(1):1. PubMed ID: 30621744
[TBL] [Abstract][Full Text] [Related]
3. A novel four-dimensional radiotherapy planning strategy from a tumor-tracking beam's eye view.
Li G; Cohen P; Xie H; Low D; Li D; Rimner A
Phys Med Biol; 2012 Nov; 57(22):7579-98. PubMed ID: 23103415
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of 4D MRI in the delineation of gross and internal tumor volumes in comparison with 4DCT.
Zhang J; Srivastava S; Wang C; Beckham T; Johnson C; Dutta P; Shepherd A; Mechalakos J; Hunt M; Wu A; Rimner A; Li G
J Appl Clin Med Phys; 2019 Sep; 20(9):51-60. PubMed ID: 31538719
[TBL] [Abstract][Full Text] [Related]
5. ITV versus mid-ventilation for treatment planning in lung SBRT: a comparison of target coverage and PTV adequacy by using in-treatment 4D cone beam CT.
Bellec J; Arab-Ceschia F; Castelli J; Lafond C; Chajon E
Radiat Oncol; 2020 Mar; 15(1):54. PubMed ID: 32127010
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].
Rao M; Wu J; Cao D; Wong T; Mehta V; Shepard D; Ye J
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e251-6. PubMed ID: 22365622
[TBL] [Abstract][Full Text] [Related]
7. A method for deriving a 4D-interpolated balanced planning target for mobile tumor radiotherapy.
Roland T; Hales R; McNutt T; Wong J; Simari P; Tryggestad E
Med Phys; 2012 Jan; 39(1):195-205. PubMed ID: 22225288
[TBL] [Abstract][Full Text] [Related]
8. 4D Monte Carlo dose calculations for pre-treatment quality assurance of VMAT SBRT: a phantom-based feasibility study.
Roberts NF; Williams M; Holloway L; Metcalfe P; Oborn BM
Phys Med Biol; 2019 Oct; 64(21):21NT01. PubMed ID: 31470421
[TBL] [Abstract][Full Text] [Related]
9. Impact of planned dose reporting methods on Gamma pass rates for IROC lung and liver motion phantoms treated with pencil beam scanning protons.
Kang Y; Shen J; Liu W; Taylor PA; Mehrens HS; Ding X; Hu Y; Tryggestad E; Keole SR; Schild SE; Wong WW; Fatyga M; Bues M
Radiat Oncol; 2019 Jun; 14(1):108. PubMed ID: 31208439
[TBL] [Abstract][Full Text] [Related]
10. Comparison of planned dose on different CT image sets to four-dimensional Monte Carlo dose recalculation using the patient's actual breathing trace for lung stereotactic body radiation therapy.
Freislederer P; von Münchow A; Kamp F; Heinz C; Gerum S; Corradini S; Söhn M; Reiner M; Roeder F; Floca R; Alber M; Belka C; Parodi K
Med Phys; 2019 Jul; 46(7):3268-3277. PubMed ID: 31074510
[TBL] [Abstract][Full Text] [Related]
11. Breathing-motion induced interplay effects for stereotactic body radiotherapy of liver tumours using flattening-filter free volumetric modulated arc therapy.
Edvardsson A; Scherman J; Nilsson MP; Wennberg B; Nordström F; Ceberg C; Ceberg S
Phys Med Biol; 2019 Jan; 64(2):025006. PubMed ID: 30618412
[TBL] [Abstract][Full Text] [Related]
12. Investigation of a novel algorithm for true 4D-VMAT planning with comparison to tracked, gated and static delivery.
Chin E; Otto K
Med Phys; 2011 May; 38(5):2698-707. PubMed ID: 21776806
[TBL] [Abstract][Full Text] [Related]
13. Verification of planning target volume settings in volumetric modulated arc therapy for stereotactic body radiation therapy by using in-treatment 4-dimensional cone beam computed tomography.
Takahashi W; Yamashita H; Kida S; Masutani Y; Sakumi A; Ohtomo K; Nakagawa K; Haga A
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):426-31. PubMed ID: 23562767
[TBL] [Abstract][Full Text] [Related]
14. Potential dosimetric benefits of adaptive tumor tracking over the internal target volume concept for stereotactic body radiation therapy of pancreatic cancer.
Karava K; Ehrbar S; Riesterer O; Roesch J; Glatz S; Klöck S; Guckenberger M; Tanadini-Lang S
Radiat Oncol; 2017 Nov; 12(1):175. PubMed ID: 29121945
[TBL] [Abstract][Full Text] [Related]
15. A planning study investigating dual-gated volumetric arc stereotactic treatment of primary renal cell carcinoma.
Devereux T; Pham D; Kron T; Foroudi F; Supple J; Siva S
Med Dosim; 2015; 40(1):82-8. PubMed ID: 25498837
[TBL] [Abstract][Full Text] [Related]
16. A 4D IMRT planning method using deformable image registration to improve normal tissue sparing with contemporary delivery techniques.
Li X; Wang X; Li Y; Zhang X
Radiat Oncol; 2011 Jul; 6():83. PubMed ID: 21771333
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric Benefits of Midposition Compared With Internal Target Volume Strategy for Esophageal Cancer Radiation Therapy.
Jin P; Machiels M; Crama KF; Visser J; van Wieringen N; Bel A; Hulshof MCCM; Alderliesten T
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):491-502. PubMed ID: 30253234
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of delivered dose to a moving target by 4D dose reconstruction in gated volumetric modulated arc therapy.
Chung H; Jung J; Jeong C; Kwak J; Park JH; Kim SS; Yoon SM; Song SY; Kim JH; Choi EK; Cho S; Cho B
PLoS One; 2018; 13(9):e0202765. PubMed ID: 30192793
[TBL] [Abstract][Full Text] [Related]
19. A novel concept to include uncertainties in the evaluation of stereotactic body radiation therapy after 4D dose accumulation using deformable image registration.
Azcona JD; Huesa-Berral C; Moreno-Jiménez M; Barbés B; Aristu JJ; Burguete J
Med Phys; 2019 Oct; 46(10):4346-4355. PubMed ID: 31402461
[TBL] [Abstract][Full Text] [Related]
20. Dynamic simulation of motion effects in IMAT lung SBRT.
Zou W; Yin L; Shen J; Corradetti MN; Kirk M; Munbodh R; Fang P; Jabbour SK; Simone CB; Yue NJ; Rengan R; Teo BK
Radiat Oncol; 2014 Nov; 9():225. PubMed ID: 25365935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
